Dr. Reddy’s launches Toripalimab for NPC in India
Hyderabad-based pharmaceutical giant Dr. Reddy’s has launched Toripalimab in India, targeting patients with nasopharyngeal carcinoma (NPC), a rare and aggressive form of head and neck…
November 28
Hyderabad-based pharmaceutical giant Dr. Reddy’s has launched Toripalimab in India, targeting patients with nasopharyngeal carcinoma (NPC), a rare and aggressive form of head and neck…
